Trinity Biotech (TRIB) Interest Expenses (2009 - 2024)

Trinity Biotech (TRIB) has reported Interest Expenses for 16 consecutive years, with $4.3 million the latest figure, recorded in Q4 2024.

• Quarterly Interest Expenses rose 83.31% year-over-year to $4.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $1.2 million (up 163.16% YoY) and the FY2025 annual result came in at $21.4 million, up 123.61% from the prior year.
• Interest Expenses climbed to $4.3 million in Q4 2024 per TRIB's latest filing, from -$3.1 million in the prior quarter.
• Over the last five years, Interest Expenses for TRIB reached as high as $4.3 million in Q4 2024 and fell as low as -$12.2 million in Q1 2022.
• A 5-year average of -$2.0 million and a median of -$1.4 million in 2021 frame the typical range for Interest Expenses.
• The largest YoY upside for Interest Expenses was 179.81% in 2022 against a maximum downside of 910.08% in 2022.
• Year by year, Interest Expenses stood at -$1.2 million in 2020, then sank by 145.18% to -$3.0 million in 2021, then jumped by 179.81% to $2.4 million in 2022, then dropped by 2.42% to $2.3 million in 2023, then surged by 83.31% to $4.3 million in 2024.
• According to Business Quant data, Interest Expenses over the past three periods registered $4.3 million, -$3.1 million, and -$2.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.